Lone Peak Global Investors LLC Boosts Holdings in Cardinal Health, Inc. $CAH

Lone Peak Global Investors LLC increased its holdings in Cardinal Health, Inc. (NYSE:CAH) by 6.1% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 121,090 shares of the company’s stock after buying an additional 6,928 shares during the period. Cardinal Health accounts for 4.0% of Lone Peak Global Investors LLC’s investment portfolio, making the stock its 5th biggest position. Lone Peak Global Investors LLC owned approximately 0.05% of Cardinal Health worth $28,766,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of CAH. LWM Advisors Inc. increased its holdings in shares of Cardinal Health by 4.4% in the second quarter. LWM Advisors Inc. now owns 1,028 shares of the company’s stock worth $244,000 after purchasing an additional 43 shares during the period. Kathmere Capital Management LLC boosted its stake in Cardinal Health by 1.2% during the first quarter. Kathmere Capital Management LLC now owns 4,242 shares of the company’s stock valued at $896,000 after buying an additional 49 shares during the period. Hillsdale Investment Management Inc. grew its position in Cardinal Health by 0.9% during the fourth quarter. Hillsdale Investment Management Inc. now owns 5,760 shares of the company’s stock worth $1,184,000 after buying an additional 50 shares in the last quarter. V Square Quantitative Management LLC increased its stake in Cardinal Health by 2.6% in the 1st quarter. V Square Quantitative Management LLC now owns 2,002 shares of the company’s stock worth $423,000 after acquiring an additional 50 shares during the last quarter. Finally, Generali Asset Management SPA SGR increased its stake in Cardinal Health by 11.0% in the 4th quarter. Generali Asset Management SPA SGR now owns 513 shares of the company’s stock worth $105,000 after acquiring an additional 51 shares during the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Price Performance

CAH opened at $239.25 on Wednesday. The firm has a market cap of $55.64 billion, a PE ratio of 33.09, a P/E/G ratio of 1.41 and a beta of 0.51. The stock has a 50-day moving average price of $233.53 and a 200-day moving average price of $218.58. Cardinal Health, Inc. has a 1 year low of $145.87 and a 1 year high of $258.30.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.42 by $0.49. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The firm had revenue of $63.67 billion for the quarter, compared to the consensus estimate of $65.15 billion. During the same quarter last year, the firm posted $2.08 EPS. The business’s quarterly revenue was up 5.8% compared to the same quarter last year. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, sell-side analysts anticipate that Cardinal Health, Inc. will post 12.55 EPS for the current year.

Cardinal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st will be issued a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend is Thursday, October 1st. Cardinal Health’s dividend payout ratio is 28.49%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on CAH shares. Morgan Stanley upped their price objective on Cardinal Health from $255.00 to $265.00 and gave the stock an “overweight” rating in a report on Wednesday, August 12th. JPMorgan Chase & Co. raised their price objective on Cardinal Health from $215.00 to $260.00 and gave the company a “neutral” rating in a report on Thursday, August 13th. Bank of America boosted their target price on Cardinal Health from $240.00 to $260.00 and gave the stock a “buy” rating in a research report on Thursday, July 2nd. UBS Group increased their price target on shares of Cardinal Health from $274.00 to $280.00 and gave the company a “buy” rating in a research report on Wednesday, August 12th. Finally, Mizuho lifted their price target on shares of Cardinal Health from $240.00 to $250.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 12th. Sixteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, Cardinal Health presently has a consensus rating of “Moderate Buy” and an average price target of $266.56.

Insider Buying and Selling at Cardinal Health

In other Cardinal Health news, insider Jessica L. Mayer sold 29,436 shares of Cardinal Health stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $236.19, for a total value of $6,952,488.84. Following the completion of the transaction, the insider directly owned 33,076 shares of the company’s stock, valued at $7,812,220.44. This trade represents a 47.09% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CEO Deborah Weitzman sold 7,354 shares of the business’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $235.45, for a total value of $1,731,499.30. Following the transaction, the chief executive officer directly owned 77,901 shares in the company, valued at approximately $18,341,790.45. This represents a 8.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 210,271 shares of company stock worth $49,626,657. Company insiders own 0.12% of the company’s stock.

Cardinal Health Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.